Ethics End of Life
Steven Hollenberg, MD, FACC, FAHA
Director, Cardiac Intensive Care
Emory University Hospital, Georgia
Disclosure information not submitted.
Ryan Maves, MD, FCCM (he/him/his)
Wake Forest University Health Sciences, North Carolina
Disclosure(s): AiCuris: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); Biotest AG: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GeoVax: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Terminated, October 20, 2024); Merck: Clinical Trial Investigator (Terminated, June 1, 2025), Grant/Research Support (Terminated, June 1, 2025); Shionogi: Advisory Board (Ongoing)
This flipped session will divide attendees into small workgroups to discuss a clinical case with an ethical dilemma. Each group will share their decision for addressing the dilemma and explain the group's rationale. The multidisciplinary expert panel will then discuss the groups’ decisions and their own opinions. This format will engage the attendees in group problem-solving while allowing the faculty to present relevant data and share their clinical thought processes. Potential scenarios might include a child with a new malignancy requiring surgery and chemotherapy whose parents are unreachable and who may be undocumented immigrants; an elderly patient with sepsis, delirium, and multisystem organ failure and no family; a man with severe traumatic brain injury after a motorcycle collision who is comatose without locatable family and differing team opinions as to treatment.
Thaddeus M. Pope, JD, PhD, HEC-C (he/him/his) – Mitchell Hamline School of Law
Rachel Hadler, MD – Emory Critical Care
Preeti R. John, MD, HEC-C, MPH, FCCM – VA Maryland Health Care System
Emily Berkman, MD, MA (she/her/hers)
